SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020800
Filing Date
2020-10-06
Accepted
2020-10-06 16:06:22
Documents
13
Period of Report
2020-10-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20201005_8k.htm   iXBRL 8-K 35239
  Complete submission text file 0001437749-20-020800.txt   168902

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blfs-20201001.xsd EX-101.SCH 3700
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20201001_def.xml EX-101.DEF 11586
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20201001_lab.xml EX-101.LAB 15466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20201001_pre.xml EX-101.PRE 11740
6 EXTRACTED XBRL INSTANCE DOCUMENT bioli20201005_8k_htm.xml XML 2560
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

IRS No.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 201226840
SIC: 3845 Electromedical & Electrotherapeutic Apparatus